NIDDK Priority HIV/AIDS Research Program

NIDDK Priority HIV/AIDS Research Program (PAS-25-073) is a targeted R01 program inside NIDDK, aligned with NIH Office of AIDS Research priorities and focused on HIV/AIDS complications that intersect with NIDDK's disease areas. The scope reaches diabetes, kidney disease, gastrointestinal and liver disease, metabolic disease, and hematologic disease. The program expects three to five awards in FY2026 and a total of $2,000,000. Clinical trial work is optional, foreign organizations are eligible, and the notice remains active through November 6, 2027. It is a US-facing NIH mechanism, but it is unusually open to international participation compared with many NIDDK calls. The best fit is a project that treats HIV/AIDS as a driver of comorbidity in one of NIDDK's mission areas rather than as a stand-alone virology study. Proposals that connect the disease biology to a clear NIDDK-relevant outcome should be strongest, especially when they can speak to NIH's AIDS research priorities and the institute's programmatic relevance. Because the award line is limited, a narrow, well-justified question will travel further than broad scope.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.